Acute Kidney Injury Mechanisms and Interventions

Acute kidney injury (AKI) is characterised by a sudden decline in renal function and carries substantial risk of both immediate morbidity and long-term progression to chronic kidney disease. At its core, AKI arises from a complex interplay of diminished perfusion, tubular epithelial injury, endothelial dysfunction and dysregulated inflammatory responses. Ischaemia–reperfusion episodes trigger hypoxic damage within cortical and medullary microvessels, leading to endothelial cell loss and microvascular rarefaction. Tubular epithelial cells succumb to apoptosis and necrosis, releasing damage signals that recruit immune cells and amplify local inflammation. Persistent oxidative stress and maladaptive repair mechanisms further promote interstitial fibrosis and capillary dropout, setting the stage for chronic decline. Interventions under investigation span advanced imaging modalities to monitor microvascular real-time changes, epigenetic modulators to restore adaptive transcriptional responses, targeted microRNA therapies to shield endothelial and tubular cells, and cell-based approaches such as endothelial progenitor or mesenchymal stem cells to enhance regenerative capacity. Together, these strategies aim not only to limit acute injury but also to prevent the transition to irreversible fibrotic remodelling.

Research from Nature Portfolio

Recent studies have pioneered non-invasive in vivo imaging of renal microvasculature using optical coherence tomography angiography. This approach reveals that moderate ischaemic insult leads to early and sustained reduction in superficial cortical blood flow, which correlates with later functional impairment and collagen deposition. Improved resolution of microvascular flow dynamics promises to refine understanding of injury severity and guide timing of therapeutic interventions. In parallel, investigations into epigenetic regulation have uncovered early hypermethylation of the vascular endothelial growth factor A (Vegfa) promoter at a hypoxia-inducible factor binding site. This aberrant methylation suppresses adaptive VEGF expression during reperfusion, contributing to persistent hypoperfusion, oxidative stress and maladaptive tissue remodelling. Finally, foundational work on lysosomal protease Cathepsin D has identified its upregulation in damaged tubular cells as a critical driver of apoptosis in toxin- and ischaemia-induced AKI. Pharmacological inhibition of Cathepsin D preserves renal function, reduces tubular cell death and attenuates interstitial fibrosis, suggesting a novel target for early intervention.

Acute Kidney Injury Mechanisms and Interventions publication trend

The graph below shows the total number of articles in acute kidney injury mechanisms and interventions across all publications each year (not limited to Nature Index journals).

Technical terms

Ischaemia–reperfusion injury: Tissue damage caused when blood supply returns to the kidney after a period of oxygen deprivation, leading to oxidative stress and inflammation.

Microvascular rarefaction: Loss or reduction of small blood vessels in the renal cortex and medulla, impairing oxygen delivery and nutrient exchange.

Epigenetic modification: Reversible chemical changes to DNA or associated proteins (such as methylation) that alter gene expression without changing the underlying sequence.

Maladaptive repair: A healing response that fails to restore normal tissue architecture, resulting in fibrosis and chronic organ dysfunction.

Apoptosis: Programmed cell death pathway that can be triggered in tubular epithelial cells during acute injury, contributing to loss of functional nephrons.

References

1. In vivo imaging of renal microvasculature in a murine ischemia–reperfusion injury model using optical coherence tomography angiography. Scientific Reports (2023).
2. Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia. Scientific Reports (2021).
3. Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury. Scientific Reports (2016).
4. miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction. Clinical Science (2024).
5. From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms. International Journal of Molecular Sciences (2022).